Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 19 studies | 38% ± 21% | |
neutrophil | 7 studies | 29% ± 8% | |
classical monocyte | 6 studies | 20% ± 6% | |
connective tissue cell | 6 studies | 30% ± 11% | |
macrophage | 4 studies | 23% ± 10% |
Insufficient scRNA-seq data for expression of TNFAIP6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 91% | 395.37 | 418 / 459 | 93% | 28.26 | 1042 / 1118 |
lung | 94% | 684.27 | 542 / 578 | 77% | 17.42 | 894 / 1155 |
esophagus | 69% | 263.47 | 991 / 1445 | 70% | 18.14 | 128 / 183 |
intestine | 65% | 244.33 | 628 / 966 | 54% | 10.48 | 286 / 527 |
stomach | 46% | 226.81 | 164 / 359 | 60% | 12.59 | 173 / 286 |
bladder | 48% | 370.29 | 10 / 21 | 55% | 10.28 | 277 / 504 |
skin | 59% | 337.67 | 1062 / 1809 | 36% | 8.08 | 172 / 472 |
kidney | 10% | 17.52 | 9 / 89 | 79% | 89.57 | 709 / 901 |
blood vessel | 87% | 400.33 | 1168 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 1672.74 | 800 / 929 | 0% | 0 | 0 / 0 |
pancreas | 2% | 3.86 | 6 / 328 | 83% | 20.79 | 148 / 178 |
adipose | 84% | 571.57 | 1015 / 1204 | 0% | 0 | 0 / 0 |
heart | 83% | 497.73 | 715 / 861 | 0% | 0 | 0 / 0 |
spleen | 74% | 192.47 | 179 / 241 | 0% | 0 | 0 / 0 |
brain | 31% | 50.90 | 820 / 2642 | 39% | 13.46 | 275 / 705 |
uterus | 22% | 48.08 | 38 / 170 | 45% | 7.97 | 205 / 459 |
ovary | 11% | 17.71 | 19 / 180 | 53% | 7.12 | 226 / 430 |
tonsil | 0% | 0 | 0 / 0 | 53% | 8.76 | 24 / 45 |
thymus | 24% | 92.44 | 158 / 653 | 20% | 2.08 | 118 / 605 |
lymph node | 0% | 0 | 0 / 0 | 41% | 12.77 | 12 / 29 |
prostate | 28% | 174.44 | 68 / 245 | 2% | 0.16 | 9 / 502 |
adrenal gland | 3% | 6.07 | 8 / 258 | 13% | 3.66 | 30 / 230 |
muscle | 15% | 36.67 | 123 / 803 | 0% | 0 | 0 / 0 |
liver | 2% | 2.18 | 5 / 226 | 12% | 4.76 | 48 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.10 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_0007165 | Biological process | signal transduction |
GO_0007155 | Biological process | cell adhesion |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0007267 | Biological process | cell-cell signaling |
GO_1905590 | Biological process | fibronectin fibril organization |
GO_0030212 | Biological process | hyaluronan metabolic process |
GO_1903911 | Biological process | positive regulation of receptor clustering |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0001550 | Biological process | ovarian cumulus expansion |
GO_0090024 | Biological process | negative regulation of neutrophil chemotaxis |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0106435 | Molecular function | carboxylesterase activity |
GO_0001968 | Molecular function | fibronectin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0005540 | Molecular function | hyaluronic acid binding |
Gene name | TNFAIP6 |
Protein name | Tumor necrosis factor-inducible gene 6 protein (EC 3.1.1.-) (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6) |
Synonyms | TSG6 |
Description | FUNCTION: Major regulator of extracellular matrix organization during tissue remodeling . Catalyzes the transfer of a heavy chain (HC) from inter-alpha-inhibitor (I-alpha-I) complex to hyaluronan. Cleaves the ester bond between the C-terminus of the HC and GalNAc residue of the chondroitin sulfate chain in I-alpha-I complex followed by transesterification of the HC to hyaluronan. In the process, potentiates the antiprotease function of I-alpha-I complex through release of free bikunin . Acts as a catalyst in the formation of hyaluronan-HC oligomers and hyaluronan-rich matrix surrounding the cumulus cell-oocyte complex, a necessary step for oocyte fertilization . Assembles hyaluronan in pericellular matrices that serve as platforms for receptor clustering and signaling. Enables binding of hyaluronan deposited on the surface of macrophages to LYVE1 on lymphatic endothelium and facilitates macrophage extravasation. Alters hyaluronan binding to functionally latent CD44 on vascular endothelium, switching CD44 into an active state that supports leukocyte rolling . Modulates the interaction of chemokines with extracellular matrix components and proteoglycans on endothelial cell surface, likely preventing chemokine gradient formation . In a negative feedback mechanism, may limit excessive neutrophil recruitment at inflammatory sites by antagonizing the association of CXCL8 with glycosaminoglycans on vascular endothelium . Has a role in osteogenesis and bone remodeling. Inhibits BMP2-dependent differentiation of mesenchymal stem cell to osteoblasts . Protects against bone erosion during inflammation by inhibiting TNFSF11/RANKL-dependent osteoclast activation . . |
Accessions | P98066 ENST00000243347.5 |